0001236030-24-000013.txt : 20240509 0001236030-24-000013.hdr.sgml : 20240509 20240509091904 ACCESSION NUMBER: 0001236030-24-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240508 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 24928952 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD STREET 2: STE 802 CITY: VIENNA STATE: VA ZIP: 22182 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-05-08 0 0000725363 CEL SCI CORP CVM 0001236030 KERSTEN GEERT R 8229 BOONE BLVD STE 802 VIENNA VA 22182 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-05-08 4 P 0 30000 1.39 A 1195309 D On May 8, 2024, Mr. Kersten purchased 30,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available. Geert Kersten 2024-05-09